Background {#Sec1}
==========

Rhinoplasty is one of the most common procedures in plastic surgery and otolaryngology \[[@CR1]\]. The indications can be functional or cosmetic, and it is essential to evaluate both components, as cosmetic nasal surgery can have functional consequences, and vice-versa. The Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) is the first patient-reported outcome measure (PROM) developed using accepted international standards to evaluate both functional and cosmetic components of rhinoplasty \[[@CR2]\].

French is one of the six official languages of the United Nations, and there are currently 274 million French speakers worldwide \[[@CR3]\]. However, there is currently no available translation of the SCHNOS questionnaire in French. To ensure semantic and conceptual equivalence, it is recommended for PROMs to be culturally adapted when administered in a population with a different language and culture \[[@CR4], [@CR5]\]. This procedure allows not only for the evaluation of patients within their own cultural context, but also produces standardized instruments for comparisons among international groups of individuals \[[@CR4]\].

The aim of this study was to carry out the translation and cultural adaptation of the SCHNOS questionnaire. The questionnaire was then validated with functional and/or cosmetic rhinoplasty patients in a French-speaking population using item-response theory (IRT) and confirmatory factor analysis (CFA).

Methods {#Sec2}
=======

The translation process and cultural adaptation was conducted with respect of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) guidelines \[[@CR5]\] (Fig. [1](#Fig1){ref-type="fig"}). This prospective validation study was conducted in two phases. The questionnaire was first translated and cross-cultural adaptation was carried out. The second phase consisted in the psychometric validation of the questionnaire. The protocol was approved by our institutional review board.Fig. 1Translation process

Questionnaire description {#Sec3}
-------------------------

The SCHNOS is a 10-item self-rated questionnaire that uses a Likert-like 0--5 scale ('no problem' to 'extreme problem'). The SCHNOS does not produce a combined total score, but two scores -- one for each domain, an obstruction score (SCHNOS-O) and a cosmesis score (SCHNOS-C). The SCHNOS-O is calculated as a sum of scores of items 1--4 divided by 20 and multiplied by 100. The SCHNOS-C score is calculated as a sum of scores of items 5--10 divided by 30 and multiplied by 100.

Translation process {#Sec4}
-------------------

Standard forward and back-translation procedure was followed. Two independent translators, both native speakers of the target language (French) and fluent in English, translated the SCHNOS questionnaire from English to French. The first and senior authors then reconciled and merged the two initial versions of each questionnaire into a harmonized French version. The harmonized version was then back-translated into English by a third independent native English-speaking translator that was unaware of the original version of the questionnaire. This back-translation was reviewed and compared with the original version to ensure that the initial concepts were respected and to identify discrepancies with the original questionnaires. Interviews were then conducted with ten rhinoplasty patients that were native French speakers. Informed written consent was obtained for all patients. During the 15-min interviews, the first author, a native French speaker and fluent in English, reviewed each questionnaire with the patients to identify ambiguities and to verify its understandability and acceptability. Patients were then asked to verbalize their perception of each item in the three questionnaires. Written notes were taken during the interviews to compile the answers. Data gathered was reviewed and modifications were made to the translated versions. Five additional interviews were conducted to review those modifications. We then performed a final proofreading and a final version of was elaborated.

Test-retest {#Sec5}
-----------

The final French version of the SCHNOS (F-SCHNOS) was administered, on two occasions, to 25 adult rhinoplasty patients and 25 controls in a tertiary Facial Plastic Surgery clinic. Exclusions criteria included rhinoplasty that was performed less than a month ago, concomitant endoscopic sinus surgery, and inability to understand written or oral French. The control group consisted of adult patients presenting for a chief complaint that was neither nasal deformity nor nasal obstruction. Informed written consent was obtained and each questionnaire was filled out on the day of consultation. Patients were contacted by phone 2 weeks later to complete the questionnaire. Spearman's rank correlation and a Wilcoxon signed-rank test for matched pairs (*p*-values) we used to compare the scores obtained for F-SCHNOS-O and F-SCHNOS-C during the 2 weeks interval.

Psychometric validation {#Sec6}
-----------------------

One hundred and sixty-five consecutive patients presenting a Facial Plastic Surgery clinic completed the F-SCHNOS, as part of routine clinical data collection. This data was then retrospectively collected after institutional review board approval.

Internal consistency was defined by a Cronbach's alpha reported along with its one-sided (lower) 95% confidence limit (95% CL). Alpha \> = 0.9 was considered excellent, 0.9 \> alpha\> = 0.8 good, 0.8 \> alpha\> = 0.7 acceptable, 0.7 \> alpha\> = 0.6 questionable, 0.6 \> alpha\> = 0.5 poor, and \< 0.5 unacceptable.

In general, the IRT analysis defines discrimination and difficulty parameters of a questionnaire. A discrimination parameter describes the sensitivity of the test to differentiate different severity levels of symptoms. The steeper the regression curve, the more discriminative the test is. In this study, discrimination of 0.01 to 0.24 was considered 'none' (a totally level regression curve), 0.25 to 0.64 was considered 'low', 0.65 to 1.34 was considered 'moderate', 1.35 to 1.69 was considered 'high'; and a discrimination ≥1.7 was considered 'perfect' (a regression curve approaching a vertical line) \[[@CR6]\]. Ideally, the steepest interval corresponds to the patients who obtained average F-SCHNOS-O or F-SCHNOS-C total scores in the studied population. In turn, the difficulty parameter refers to the level of a perceived nasal problem needed to achieve a 50% probability of choosing a particular score. In an ideal situation, patients who experience an average nasal problem (in this particular population) should have a 0.5 probability of getting a score located at the middle of a scale. Thus, in this "best possible" example, the responses of '0' or '1' points in SCHNOS items would produce 'difficulty estimates' with a minus sign, indicating that the respondent perceived a lower level of symptoms than the average within the population. Respectively, estimates for responses with '4' and '5' points would carry a positive sign, indicating that the respondent perceived higher levels of symptoms than the average within this population. The IRT Rating Scale Model (RSM) was used. Item information and test characteristic curves and the test information functions were presented graphically. All the IRT and other analyses (except CFA) were performed using Stata/IC Statistical Software: Release 15, College Station (StataCorp LP, TX, USA).

The root mean square error of approximation (RMSEA) was used as a primary indicator of the goodness of model fit in CFA. The modification indices suggested by the software were used to impute covariances between factors one at a time, each time testing the RMSEA closeness to the value of ≤0.05 (the threshold for accepting the model fit). The relative chi-squared test was used to reduce dependence on the sample size with value \< 3.0 pointed to an acceptable fit. The CFA was conducted using IBM® SPSS® Amos™, Version 25.0 (IBM® Corp. Released 2017, PA, USA).

All *p*-values was considered statistically significant if = \< 0.05 when not mentioned otherwise.

Results {#Sec7}
=======

Translation and cultural adaptation {#Sec8}
-----------------------------------

There were multiple differences between the two forward translations, which were reconciled and harmonized, as shown in Table [1](#Tab1){ref-type="table"}. Back-translation showed only minimal discrepancies with the original concepts requiring no further modification. Ten interviews were conducted with two preoperative and eight postoperative rhinoplasty patients (four women, six men, mean age 39.4). Three modifications were made after cognitive interviews: \[[@CR1]\] the word *du* in the introduction was underlined, \[[@CR2]\] we added *(bout du nez)* at the end of item no. 6 to clarify pointe du nez, and \[[@CR3]\] item no.7 was modified to add *(vu de face)* at the end of the sentence. These modifications were presented to five additional postoperative rhinoplasty patients (two women, three men). The final version and scoring of the final French version compared to the original English version is seen in Fig. [2](#Fig2){ref-type="fig"}.Table 1Reconciliation of forward translations\# ItemOriginal version (English)Forward translation no.1Forward translation no.2Harmonized versionRationale2Getting air through my nose during exerciseRespirer par le nez au cours de l'exercice physiqueDifficulté à respirer par le nez pendant l'activité physiqueDifficulté à respirer par le nez pendant l'exercice physiqueResearchers chose the second translation, as it is more accurate in relation to the introduction statement. Adding *difficulté à* reflects more precisely the idea that "getting air through the nose during exercise" is a problem.3Having a congested noseAvoir le nez congestionnéNez congestionnéNez congestionnéResearchers discussed that both translations had the same meaning, but the second translation was shorter and simpler5Decreased mood and self-esteem due to my noseMauvaises humeur et estime de soi à cause de mon nezPerte d'humeur ou d'estime de moi à cause de mon nezMauvaises humeur et estime de soi à cause de mon nezResearchers discussed that the first translation reflected more properly the original concept in the English version7The straightness of my noseÀ quel point mon nez est. droitLa rectitude de mon nezÀ quel point mon nez est. droitThe first translation was chosen, as it is a colloquial expression of more common usage in the French speaking population than the word "rectitude".9How well my nose suits my faceCombien mon nez convient à mon visageComment mon nez s'agence avec mon visageComment mon nez s'agence avec mon visageResearchers discussed that in French, the first translation was more of quantification and would reflect "how much" instead of "how well". The second translation is a qualifier and thereby conceptually equivalent to the original version.Fig. 2The structures and scoring formulas of English and French versions of SCHNOS

Test-retest {#Sec9}
-----------

Of the 52 patients invited to answer the questionnaires, 50 were recruited (96% response rate). The patient group consisted of 15 women and 11 men (mean age 40.1 years) presenting for preoperative (*n* = 12) or postoperative (*n* = 13) rhinoplasty appointments. The patient group consisted of 13 women and 12 men (mean age 49.9 years) presenting for a variety of non-rhinoplasty related reasons (Mohs' reconstruction of non-nasal sites, facial paralysis, temporomandibular disorders, facial trauma, trigeminal neuralgia, among others). The spearman's rank correlation for SCHNOS-O and SCHNOS-C were positive and statistically significant (SCHNOS-O: *r* = 0,606 on 50 observations (95% CI: 0,294 to 0,757); SCHNOS-C: *r* = 0,762 on 50 observations (95% CI: 0,614 to 0,859)). No statistical significance was found in responses obtained in the Wilcoxon signed-rank test for SCHNOS-C (*p* = 0,5920). There was a significant difference for the SCHNOS-O (*p* = 0,0060).

Psychometric validation {#Sec10}
-----------------------

The results from IRT analysis are available from 165 individual patients (75 female, 89 male; 69 septorhinoplasty, 95 non-septorhinoplasty; mean age 48.6 years) and are shown in Table [2](#Tab2){ref-type="table"} for F-SCHNOS-O and Table [3](#Tab3){ref-type="table"} for F-SCHNOS-C. The internal consistency of F-SCHNOS-O was good with alpha 0.93 (lower 95% CL 0.92). The discrimination ability of F-SCHNOS-O was perfect 2.18 (*p* \< 0.001, 95% CI 1.74 to 2.62). Even though some steps up or down across the SCHNOS-O scale were insignificant, most of them were associated with a meaningful differences in severity of the measured nasal problem perceived by a patient (Table [2](#Tab2){ref-type="table"}). The difficulty estimates demonstrated an ideal distribution around the middle point of the F-SCHNOS-O scale -- step 3 vs. 2. For the entire F-SCHNOS-O score, most information could be obtained around the average level of perceived problem (Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}). The CFA model of F-SCHNOS-O did not achieve the level of statistical significance with RMSEA 0.08 (Table [4](#Tab4){ref-type="table"}). However, it seems that all four items were equally "important" in defining the total SCHNOS-O score -- correlations varied from 0.87 to 0.94 (Fig. [5](#Fig5){ref-type="fig"}). There was one imputed covariance between items \#2 and \#3.Table 2Difficulty parameters of F-SCHNOS-O item -- Rating Scale Model RSM (*n* = 165)ItemStepDifficulty*p*-value95% CISCHNOS 11 vs. 0−0.270.020−0.50−0.042 vs. 1−0.370.003−0.61− 0.133 vs. 20.040.749−0.190.264 vs. 30.43\< 0.0010.220.655 vs. 41.37\< 0.0011.091.66SCHNOS 21 vs. 0−0.080.486−0.300.142 vs. 1−0.180.131−0.420.053 vs. 20.230.0470.000.454 vs. 30.62\< 0.0010.400.855 vs. 41.56\< 0.0011.261.87SCHNOS 31 vs. 0−0.260.022−0.49−0.042 vs. 1−0.370.003−0.61−0.133 vs. 20.040.719−0.180.264 vs. 30.44\< 0.0010.220.665 vs. 41.38\< 0.0011.091.66SCHNOS 41 vs. 0−0.170.146−0.390.062 vs. 1−0.270.027−0.51−0.033 vs. 20.140.220−0.080.364 vs. 30.54\< 0.0010.320.765 vs. 41.48\< 0.0011.181.77Table 3Difficulty parameters of F-SCHNOS-C item -- Rating Scale Model RSM (*n* = 163)ItemStepDifficulty*p*-value95% CISCHNOS 51 vs. 00.67\< 0.0010.480.862 vs. 10.44\< 0.0010.240.643 vs. 20.63\< 0.0010.430.834 vs. 31.09\< 0.0010.861.325 vs. 41.21\< 0.0010.961.46SCHNOS 61 vs. 01.02\< 0.0010.801.242 vs. 10.79\< 0.0010.581.003 vs. 20.98\< 0.0010.761.204 vs. 31.44\< 0.0011.171.725 vs. 41.56\< 0.0011.271.86SCHNOS 71 vs. 00.73\< 0.0010.540.922 vs. 10.50\< 0.0010.300.703 vs. 20.69\< 0.0010.480.894 vs. 31.15\< 0.0010.921.395 vs. 41.27\< 0.0011.011.53SCHNOS 81 vs. 00.79\< 0.0010.590.992 vs. 10.56\< 0.0010.350.763 vs. 20.74\< 0.0010.540.954 vs. 31.21\< 0.0010.971.455 vs. 41.33\< 0.0011.061.59SCHNOS 91 vs. 00.88\< 0.0010.681.092 vs. 10.65\< 0.0010.450.863 vs. 20.84\< 0.0010.631.054 vs. 31.30\< 0.0011.051.565 vs. 41.42\< 0.0011.151.70SCHNOS 101 vs. 00.80\< 0.0010.601.002 vs. 10.57\< 0.0010.360.773 vs. 20.75\< 0.0010.550.964 vs. 31.22\< 0.0010.981.465 vs. 41.34\< 0.0011.071.60Fig. 3Test characteristic curve of F-SCHNOS-OFig. 4Test information function of F-SCHNOS-OTable 4Construct of F-SCHNOS-OMethodValueRoot mean squared residual (RMR)0.03Goodness of fit index (GFI)0.99Adjusted goodness of fit index (AGFI)0.93Parsimony goodness of fit index (PGFI)0.10Bentler-Bonett normed fit index (NFI)1.00Bollen's relative fit index (RFI)0.98Bollen's incremental fit index (IFI)1.00Tucker-Lewis coefficient (TLI)0.99Bentler's comparative fit index (CFI)1.00Parsimony ratio (PRATIO)0.17Parsimony adjustment to the NFI (PNFI)0.17Parsimony adjustment to the CFI (PCFI)0.17Akaike information criterion (AIC)20Browne-Cudeck criterion (BCC)21Bayes information criterion (BIC)47Bozdogan's consistent AIC (CAIC)56Hoelter's 'critical N' for a significance level of .05 (HOELTER .05)272Hoelter's 'critical N' for a significance level of .01 (HOELTER .01)469MethodValue90% CINoncentrality parameter (NCP)1.00.09.4Minimum value of the discrepancy (FMIN)0.010.00.07Root mean squared error of approximation (RMSEA)0.080.00.26Except for a constant scale factor (ECVI)0.140.130.2MethodValueDF*p*-valueCMIN/DFMinimized value of the discrepancy function (CMIN)2.010.162.0Tests of the goodness of fit used. All figures are shown for the default model fitFig. 5Path diagram of factor structure of F-SCHNOS-O. Circles represent unmeasured variables (in terms of factor analysis, 'latent traits', 'constructs', or 'factors'), while square shapes represent measured observed variables (the SCHNOS items in this study). Factor loadings (relationships between observed variables and a factor/unmeasured variable) are marked as single-headed arrows. Correlations between two unobserved variables are shown as two-headed arrows. Conventionally, measurement errors are presented as smaller circles denoted as "e1", "e2", etc. Numbers in bold by the square shapes are coefficients of determination, displaying how much of the total variance of a latent factor is explained by the variance present in a particular observed variable. Other numbers in the diagram show the strengths of loadings and correlations

The internal consistency of F-SCHNOS-C was good -- alpha 0.95 (lower 95% CL 0.94). The discrimination ability of F-SCHNOS-C was perfect -- 2.62 (*p* \< 0.001, 95% CI 2.03 to 3.21). All the steps up or down across the F-SCHNOS-C scale were associated with a meaningful difference in severity of the measured nasal problem perceived by a patient (Table [3](#Tab3){ref-type="table"}). When analyzing the difficulty parameter for F-SCHNOS-C items, the scale tended to underestimate the severity of cosmetic disadvantage experienced by patients. In other words, a patient who has placed a mark on the lower end of the scale might experience more cosmetic disadvantage than on average in the studied population. Respectively, the information curve of F-SCHNOS-C was shifted towards greater severity of symptoms (Figs. [6](#Fig6){ref-type="fig"} and [7](#Fig7){ref-type="fig"}). The CFA model for F-SCHNOS-C did not achieve the level of clinical significance -- RMSEA 0.08 (Table [5](#Tab5){ref-type="table"}). However, it seems that items \#7, \#8, \#9 and \#10 define the total F-SCHNOS-C score much more than items \#5 and \#6 (Fig. [8](#Fig8){ref-type="fig"}). Three covariances needed to be added to the model.Fig. 6Test characteristic curve of F-SCHNOS-CFig. 7Test information function of F-SCHNOS-CTable 5Construct of SCHNOS-CMethodValueRoot mean squared residual (RMR)0.05Goodness of fit index (GFI)0.97Adjusted goodness of fit index (AGFI)0.90Parsimony goodness of fit index (PGFI)0.28Bentler-Bonett normed fit index (NFI)0.99Bollen's relative fit index (RFI)0.97Bollen's incremental fit index (IFI)0.99Tucker-Lewis coefficient (TLI)0.99Bentler's comparative fit index (CFI)0.99Parsimony ratio (PRATIO)0.40Parsimony adjustment to the NFI (PNFI)0.40Parsimony adjustment to the CFI (PCFI)0.40Akaike information criterion (AIC)42Browne-Cudeck criterion (BCC)44Bayes information criterion (BIC)86Bozdogan's consistent AIC (CAIC)101Hoelter's 'critical N' for a significance level of .05 (HOELTER .05)150Hoelter's 'critical N' for a significance level of .01 (HOELTER .01)200MethodValue90% CINoncentrality parameter (NCP)6.00.019.9Minimum value of the discrepancy (FMIN)0.080.00.14Root mean squared error of approximation (RMSEA)0.080.00.15Except for a constant scale factor (ECVI)0.300.250.39MethodValueDF*p*-valueCMIN/DFMinimized value of the discrepancy function (CMIN)12.060.062.0Tests of the goodness of fit used. All figures are shown for the default model fitFig. 8Path diagram of factor structure of F-SCHNOS-C. Circles represent unmeasured variables (in terms of factor analysis, 'latent traits', 'constructs', or 'factors'), while square shapes represent measured observed variables (the SCHNOS items in this study). Factor loadings (relationships between observed variables and a factor/unmeasured variable) are marked as single-headed arrows. Correlations between two unobserved variables are shown as two-headed arrows. Conventionally, measurement errors are presented as smaller circles denoted as "e1", "e2", etc. Numbers in bold by the square shapes are coefficients of determination, displaying how much of the total variance of a latent factor is explained by the variance present in a particular observed variable. Other numbers in the diagram show the strengths of loadings and correlations

Discussion {#Sec11}
==========

We were able to translate, adapt, and validate the SCHNOS into French, producing the F-SCHNOS. This French version was shown to be conceptually and psychometrically equivalent to the original English version. The meticulous process of translation and cultural adaptation is supported by many international guidelines \[[@CR4], [@CR5], [@CR7]\].

This multistep procedure is of paramount importance is order to achieve not only semantic equivalence, but to ensure that the original content and concepts are respected and adapted to the population which the instrument targets.

The F-SCHNOS is a reliable instrument, as demonstrated by a high internal consistency for both SCHNOS-O and SCHNOS-C. These results are very similar to the Cronbach's alpha of the original English version \[[@CR2]\]. It is also a valid instrument, which refers to its ability to measure accurately the outcome of interest. Multiple analyses are required in order to prove validity \[[@CR8]\], as it has already been demonstrated for the original English version of the SCHNOS \[[@CR9]\]. The positive and significant correlation between each item of the F-SCHNOS-O and F-SCHNOS-C is a demonstration. The methodology used for the translation process is also a safeguard of content validity.

In the test-retest phase of the study, we demonstrated the reproducibility of our instrument. The participants in this study answered in a positively correlated manner between the 2 weeks interval for both SCHNOS-O and SCHNOS-C. Furthermore, for the SCHNOS-C, their answers were not significantly different in the 2 weeks interval, which highlight the proper reproducibility of our instrument. There was although a significant difference for the SCHNOS-C in the Wilcoxon signed-rank test. We think that the method of administration of the questionnaire might have had an influence over this result. Since aesthetic appearance of the nose is a more sensitive subject for many patients, they might have been more reluctant to answer sincerely by phone at the 2 weeks interval than at the first consultation, were the questionnaire was filled in writing.

The small number of participants recruited for the psychometric validation is a limitation to this study. However, many similar translation studies achieved a validation process with similar or a more limited number of participants \[[@CR10]--[@CR13]\]. Furthermore, a small sample size would only diminish the chances of finding a significant association. Since our results showed the reliability and validity of the French SCHNOS, especially with IRT, we believe that the associations would only be stronger with a larger sample size.

This study is the first one to generate a French-language version of the SCHNOS questionnaire. Such adapted questionnaires are important in health-related quality of life evaluation. They are useful for screening and monitoring the individual patient and in the evaluation of health outcomes \[[@CR14]\]; but also providing comparable results for international research \[[@CR4]\].

Conclusions {#Sec12}
===========

In conclusion, we successfully translated, adapted, and validated the SCHNOS into French in order to help with the evaluation of functional and cosmetic outcomes of rhinoplasty patients. We hope that this will provide an additional tool to the clinician who is evaluation the French-speaking rhinoplasty patient.

CFA

:   Confirmatory factor analysis

IRT

:   Item Reponse Theory

ISPOR

:   International Society for Pharmacoeconomics and Outcomes Research
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:   Patient-reported outcome measure
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:   Rating Scale Model

RMSEA

:   Root mean square error of approximation

SCHNOS

:   Standardized Cosmesis and Health Nasal Outcome Survey

SCHNOS-C

:   Standardized Cosmesis and Health Nasal Outcome Survey -- Cosmesis domain

SCHNOS-O

:   Standardized Cosmesis and Health Nasal Outcome Survey: Obstruction domain
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